A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
A Multi-Step Approach for Accurate & Timely Data
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
Many ophthalmic companies and practices entered 2020 seeing the date as a marketing gift to promote all things related to quality vision. It was to be a banner year. 2020 ended with the number perm...
Alcon on Jan. 7 announced the commercial launch of the AcrySof IQ Vivity non-diffractive extended depth of focus (EDOF) IOL, including a toric version, in the US. We project the Vivity will help dr...
The ophthalmic market continues to expand and attract funding from investors. There were more deals in 2020 than the two previous years, and transactions totaled $8.6 billion. Retina is the largest...
Kala Pharmaceuticals announced Jan. 7 that it had launched Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dr...
French company Pixium Vision and Second Sight Medical Products, of California, announced Jan. 6 that the two would combine operations. Pixium will contribute to Second Sight all of its assets and l...
A US spending package signed into law on Dec. 27 erased the impact of Medicare’s negative physician fee adjustments for eye care providers in 2021. Ophthalmologists were prepared to see an average ...
The US FDA’s ophthalmic devices division granted four clearances through the 510(k) pathway in December 2020, according to the agency’s database. One involved adding an indication for use to an alr...
Market Scope polled companies and practices to rank our list of top 10 ophthalmic stories for 2020. Not surprisingly, both groups chose the COVID-19 pandemic as the No. 1 story. Corporate participa...
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.